STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
NCT01367665
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1232
Enrollment
INDUSTRY
Sponsor class
Conditions
Basal Cell Carcinoma
Interventions
DRUG:
vismodegib
Sponsor
Hoffmann-La Roche